Botulinum toxin A injections for the treatment of Schwartz-Jampel syndrome: a case series.

Abstract

Schwartz-Jampel syndrome is a rare autosomal recessive disorder characterized by myotonia and skeletal dysplasia. Botulinum toxin A is emerging as a therapeutic option for patients with this syndrome. This study describes the use of botulinum toxin A in 4 children with Schwartz-Jampel syndrome. The response to this therapeutic modality was limited and variable.

• Authors: Samah Khalil Aburahma, Taiseer Al-Khateeb, Ali Alrefai, Zouhair Amarin
• Journal: Journal of child neurology (J Child Neurol) Vol. 24 Issue 1 Pg. 5-8 (Jan 2009) ISSN: 1708-8283 [Electronic] United States
• PMID: 19168812 (Publication Type: Case Reports, Journal Article)

Chemical References

• Neuromuscular Agents
• Botulinum Toxins, Type A

Topics

• Botulinum Toxins, Type A (therapeutic use)
• Child
• Child, Preschool
• Female
• Humans
• Male
• Neuromuscular Agents (therapeutic use)
• Osteochondrodysplasias (drug therapy)